1/4

Export Ready

ITRARAN 200 CAPSULES

Name: ITRARAN 200 CAPSULES
Brand: itraran 200
SKU: 8516173
Price: 3.03 USD
Availability: InStock

Sold by ranguard healthcare limited · Contractor, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Noida, Uttar Pradesh, India

Price

₹ 3.03 /Unit

In stock

Inclusive of all taxes

Minimum order: 1 Unit

Export Snapshot

MOQ

1 Unit

Lead time

On request

Packaging

200 capsules per container

Shelf life / longevity

As per product specification

HS Code

30049099

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for ranguard healthcare limited.

Compliance & Certifications

Suitable for

Importers · Distributors · Wholesalers

Noida Dispatch on request Verified seller

ranguard healthcare limited

Contractor, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Noida, Uttar Pradesh, India

RANGUARD HEALTHCARE LIMITED "Poineering a healthier Tomorrow" ISO 9001:2015,WHO-GMP CERTIFIED COMPANY RANGUARD HEALTHCARE Limited is a pharmaceutical company with a bold vision to redefine healthcare delivery through innovation, Integrity, and compassion. ThOUgh new to the industry, we are built on a strong foundation of ethical practices, collaborative spirit, and an unwavering focus on putting patients first. As a next-generation healthcare company, our mission is to make a meaningfUl contribution to global wellness by supporting healthcare professionals and enhancing the lives of patients. We aspire to become a trusted name in the pharmaceutical sector by delivering high-quality, affordable, and accessible medical solutions that extend not just life spans bUt health-spans.With a deep commitment to excellence and sustainability, RANGUARD HEALTHCARE is poised to drive transformative change in the industry. We are guided by the belief that healthcare should be inclusive, innovative, and inspired by purpose. By fostering partnerships and embracing scientific advancement, we aim to build a healthier future for communities. across the globe. As we begin this exciting joUrney, we remain dedicated to our promise providing effective, safe, and affordable healthcare products and solutions that empower lives and promote long-term wellness. “Quality You Can Trust. Care You Deserve.“

Registered address: Noida, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

View profile All products

Established

2024

Employees

1–10

GST

09AAOCR0046G1ZB

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Jul 2025

Turnover

10000001 - 50000000.

Incorporation Type

On request

Verified Seller

Product details

What are the specifications of this product?

Overview

ITRACONAZOLE 200 FOR Systemic and deep fungal infections, Dermatophytoses (skin fungal infections),Onychomycosis (fungal nail infection),Coccidioidomycosis (Mild to Moderate Cases)Alternative to fluconazole,.Chromoblastomycosis Chronic cutaneous fungal infection caused by pigmented fungi (e.g., Fonsecaea) Capsules require acidic gastric environment for absorption. Take with food. Blastomycosis Causative organism: Blastomyces dermatitidis Histoplasmosis Causative organism: Histoplasma capsulatum

Product Description

According to FDA labeling, Itraconazole capsules are approved for the treatment of the following systemic fungal infections:

1. Blastomycosis

Causative organism: Blastomyces dermatitidis

Types: Pulmonary and extrapulmonary (non-meningeal)

✅ Itraconazole is approved for treatment of both acute and chronic forms.

2. Histoplasmosis

Causative organism: Histoplasma capsulatum

Types:

Chronic cavitary pulmonary histoplasmosis

Disseminated (non-meningeal) histoplasmosis

✅ Itraconazole is used for mild to moderate disease, and for long-term oral therapy.

3. Onychomycosis of the Toenail (with or without fingernail involvement)

Causative organism: Dermatophytes, mainly Trichophyton rubrum

✅ Approved for treatment of onychomycosis only when:

Nail matrix is involved

Diagnosis confirmed by lab testing (e.g., KOH prep, culture)

Description provided by ranguard healthcare limited.

Specifications

Dosage Strength	200 mg per capsule
Packaging	200 capsules per container
Storage Conditions	Store below 30°C, protect from moisture and light
Administration Route	Oral
Pharmacological Class	Antifungal agent
Mechanism of Action	Inhibits fungal cytochrome P450 enzyme resulting in impaired ergosterol synthesis
Absorption	Enhanced by acidic gastric environment
Common Dosage Regimen	Administered with food to increase bioavailability
Contraindications	Patients with ventricular dysfunction or history of heart failure
Drug Interactions	Avoid co-administration with CYP3A4 substrates metabolized drugs without medical supervision

Use cases

Category	packaging > pharmaceutical packaging > empty capsules
Primary application	Wholesale, distribution, and international sourcing
Brand	itraran 200
Product type	Product

Logistics & handling

Lead time	On request
Packaging	200 capsules per container
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing ITRARAN 200 CAPSULES. Answers compiled from verified sellers' commercial terms and platform data.

Q: What is the recommended administration condition for optimal absorption of ITRARAN 200 Capsules?

A: ITRARAN 200 Capsules require an acidic gastric environment for effective absorption; hence, it should be taken with food to enhance bioavailability.

Q: Can ITRARAN 200 be used to treat both pulmonary and extrapulmonary forms of blastomycosis?

A: Yes, according to FDA guidelines, ITRARAN 200 Capsules are approved to treat both pulmonary and extrapulmonary (non-meningeal) forms of blastomycosis.

Q: Is laboratory confirmation necessary before initiating ITRARAN 200 Capsules for onychomycosis?

A: Yes, treatment with ITRARAN 200 Capsules for onychomycosis is approved only when the nail matrix is involved and diagnosis is confirmed by laboratory tests such as KOH prep or fungal culture.

Q: How does ITRARAN 200 Capsules compare to fluconazole for treating fungal infections?

A: ITRARAN 200 Capsules serve as an effective alternative to fluconazole, particularly in treating systemic and deep fungal infections due to their broad spectrum and potent antifungal activity.

Q: Are ITRARAN 200 Capsules suitable for use in chronic cutaneous chromoblastomycosis?

A: Yes, ITRARAN 200 Capsules have proven efficacy in treating chromoblastomycosis, a chronic cutaneous fungal infection caused by pigmented fungi such as Fonsecaea species.

Question not answered? Ask sellers directly — typical response within 4 hours.